{"schema_version":"secwatch.filing_event.v1","accession":"0000072331-25-000138","form_type":"8-K","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.013269+00:00","generated_at":"2026-05-16T13:42:46.452580+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nordson reports record FY2025 sales of $2.8B; adj. EPS $10.24, up 5% YoY","bullets":["Q4 sales $752M (+1% YoY); diluted EPS $2.69; adj. diluted EPS $3.03 (+9% YoY).","FY2025 record sales $2.8B (+4%); net income $484M ($8.51 diluted EPS); adj. EPS $10.24.","Medical & Fluid Solutions sales up 10% YoY; Industrial Precision down 2%; Advanced Tech down 4%.","FY2026 guidance: sales $2.83B-$2.95B; adj. EPS $10.80-$11.50; backlog ~$600M (+5% ex-divestiture).","Record free cash flow $661M (136% conversion); EBITDA margin 32% for FY2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000072331-25-000138","json":"https://secwatch.observer/filing/0000072331-25-000138.json","markdown":"https://secwatch.observer/filing/0000072331-25-000138.md","text":"https://secwatch.observer/filing/0000072331-25-000138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000138/0000072331-25-000138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000138/ndsn-20251210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:42:46.452580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}